|
High $0.32 |
Low $0.30 |
Trades 243 |
Turnover $627,825 |
Volume 2,012,212 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (14-Nov) $36,843,036 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (9-Nov) 20,215,263 (1.37%) (219th) |
|
52w High $0.470 |
52w Low $0.020 |
P/E 7.20 |
EPS -0.05 |
[ARTICLE] Immutep shares surge 8pc on FDA validation of its immune checkpoint
A news article has been posted about Immutep on the AFR. The article was published around , on 21 March 2022 at 2:31pm.
Immunotherapy biotech Immutep shares surged 8 per cent in morning trade on Monday, buoyed by news the FDA had approved Bristol Myers Squibb’s LAG-3 drug.
Read ArticleIMM was $0.40 at the close of trade on 18 March 2022
Find all articles about Immutep, including others on the AFR, on the media page.
If you were already registered, log in here.